Rivulet Media Inc (fka RIVU)

[coloradoKid]

Interesting is what I gleamed from the 10Q:

1) BMSN is now current and ready for uplist
2) BMSN is only 1.7M in debt. For a company with a huge funding guarantee in which common stock is traded for cash, the company chose to hold debt rather than dilute. This means that the company knows the pps will be going up in the not too distant future.
3) CEO has a lot of his own personal money in this thing.
4) OS as of 12/31 was only 1B. That means the ~200M shares issued since is probably it for this stage of the game.

Predictions:
1) uplist news should be next. This will set the stage for all sorts of good news coming down the pipe.
2) progress on wrapping up the IND application should follow.
3) clinical trials partner will be announced next
3b) if we are lucky, orphan drug status is announced here.
4) completion of the app and approval to proceed with trials will be right after that.
5) new funding strategy to pay for phase 1&2
6) followed by progress reports of said trials.
7) if all goes well a JV announcement defining the company who will do the Phase 3 trials and bring the product to market.

That is how I see the future. Any thoughts?